Factors associated with adherence to nucleos(t)ide analogs in chronic hepatitis B patients: results from a 1-year follow-up study
Jie Peng, Junhua Yin, Shaohang Cai, Tao Yu, Chunxiu Zhong Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, People’s Republic of China Abstract: Little is known about the factors associated with patient compliance with nucleos(t)ide analog (NUC) treatment for...
Main Authors: | Peng J, Yin JH, Cai SH, Yu T, Zhong CX |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-01-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/factors-associated-with-adherence-to-nucleostide-analogs-in-chronic-he-peer-reviewed-article-PPA |
Similar Items
-
Stopping nucleos(t)ide analog treatment in chronic hepatitis B — Who and when?
by: Suzette Grace R. Kho-Herman, et al.
Published: (2017-09-01) -
Impact of nucleos(t)ide analogues on quality of life in patients with chronic hepatitis B
by: ZHONG Chunxiu, et al.
Published: (2016-11-01) -
Predictors of sustained virologic response after discontinuation of nucleos(t)ide analog treatment for chronic hepatitis B
by: Jie Peng, et al.
Published: (2015-01-01) -
Host genetic factors in predicting response status in chronic hepatitis B patients discontinuing nucleos(t)ide analogs
by: Tao Li, et al.
Published: (2018-01-01) -
Adherence to Nucleos(t)ide Analogue Therapies for Chronic Hepatitis B Infection: A Systematic Review and Meta‐Analysis
by: Nathan Ford, et al.
Published: (2018-10-01)